Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation

Clinical trial NCT00464165 · COMPLETED

Trial details

NCT number: NCT00464165
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2002-11-01
Primary completion: 2003-10-01
Enrollment: 789

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.